Gerashchenko Tatiana S, Novikov Nikita M, Krakhmal Nadezhda V, Zolotaryova Sofia Y, Zavyalova Marina V, Cherdyntseva Nadezhda V, Denisov Evgeny V, Perelmuter Vladimir M
Laboratory of Molecular Oncology and Immunology, Cancer Research Institute, Tomsk National Research Medical Center, 634009 Tomsk, Russia.
Department of Cytology and Genetics, Tomsk State University, 634050 Tomsk, Russia.
J Clin Med. 2019 Jul 24;8(8):1092. doi: 10.3390/jcm8081092.
Invasion, or directed migration of tumor cells into adjacent tissues, is one of the hallmarks of cancer and the first step towards metastasis. Penetrating to adjacent tissues, tumor cells form the so-called invasive front/edge. The cellular plasticity afforded by different kinds of phenotypic transitions (epithelial-mesenchymal, collective-amoeboid, mesenchymal-amoeboid, and ) significantly contributes to the diversity of cancer cell invasion patterns and mechanisms. Nevertheless, despite the advances in the understanding of invasion, it is problematic to identify tumor cells with the motile phenotype in cancer tissue specimens due to the absence of reliable and acceptable molecular markers. In this review, we summarize the current information about molecules such as extracellular matrix components, factors of epithelial-mesenchymal transition, proteases, cell adhesion, and actin cytoskeleton proteins involved in cell migration and invasion that could be used as invasive markers and discuss their advantages and limitations. Based on the reviewed data, we conclude that future studies focused on the identification of specific invasive markers should use new models one of which may be the intratumor morphological heterogeneity in breast cancer reflecting different patterns of cancer cell invasion.
肿瘤细胞侵入或定向迁移至邻近组织是癌症的标志之一,也是转移的第一步。肿瘤细胞穿透至邻近组织,形成所谓的侵袭前沿/边缘。不同类型的表型转变(上皮-间质、集体-阿米巴样、间质-阿米巴样等)所赋予的细胞可塑性显著促成了癌细胞侵袭模式和机制的多样性。然而,尽管在侵袭理解方面取得了进展,但由于缺乏可靠且可接受的分子标记物,在癌症组织标本中识别具有运动表型的肿瘤细胞仍存在问题。在本综述中,我们总结了有关参与细胞迁移和侵袭的分子的当前信息,如细胞外基质成分、上皮-间质转化因子、蛋白酶、细胞黏附以及肌动蛋白细胞骨架蛋白等,这些分子可作为侵袭标记物,并讨论了它们的优缺点。基于综述数据,我们得出结论,未来专注于识别特定侵袭标记物的研究应采用新模型,其中之一可能是反映癌细胞不同侵袭模式的乳腺癌肿瘤内形态异质性。